Study reveals extent of lung scarring after COVID hospitalisation

The interim analysis of the UK Interstitial Lung Disease Post COVID study reveals extent of lung scarring after COVID hospitalisation.

Study of long-term impacts of lung damage from COVID-19

The study, launched with £2 million of funding from UKRI and led by Imperial, aims to develop treatment strategies and prevent disability

The launch of the Margaret Turner-Warwick Centre for Fibrosing Lung Disease

On the 4 November 2021, the Margaret Turner-Warwick Centre for Fibrosing Lung Disease (MTWC) launched.

Margaret Turner Warwick Centre at GERF

Dr Laura Fabbri and Dr Alison John ran an activity entitled ‘Can we take your breath away?’ on behalf of the Margaret Turner Warwick Centre